Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 5:04 AM
Ignite Modification Date:
2025-12-25 @ 5:04 AM
NCT ID:
NCT05922618
Eligibility Criteria:
Inclusion Criteria:
* Diagnosis of type I CRPS according to the Budapest criteria (table 1)
* Type I CRPS involving the ankle or foot
* Onset of CRPS type I up to a maximum of 3 years after the symptomatic event
* Pain on visual analog scale (VAS) scale quantified as intensity at least ≥ 5 at recruitment
* Pharmacological treatment with first infusion cycle of neridronate
Exclusion Criteria:
* Neurological pathologies (stroke, degenerative, traumatic pathologies)
* Local neurological impairment (type II CRPS), confirmed by a conduction test or similar
* Cardiac pacemaker, treatment site malignancy
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT05922618
Study Brief:
Protocol Section:
NCT05922618